Top

Tag: drug manufacturing


Biotech, Industry

Genetic Engineering Across the Tree of Life

September 21, 2020

Via: Genetic Engineering and Biotechnology News

Industrial bioengineering is now using genetically modified microbes to produce a wide array of products at industrial scale, including everything from biofuels to nutraceuticals such as resveratrol. But despite the diversity of output, the primary organisms producing them are modified […]


Industry, Vaccines

Moderna says it will begin developing a vaccine for seasonal flu

September 17, 2020

Via: CNBC

Biotech firm Moderna said Thursday it will begin developing a vaccine for the influenza season. “We are announcing that we are increasing our investment in vaccines and we will develop a seasonal flu vaccine given the unmet need for highly […]


Industry, Vaccines

Automation a Key Focus for Moderna’s COVID-19 Vaccine Contractor

September 15, 2020

Via: Genetic Engineering and Biotechnology News

Moderna hired Lonza to make its COVID-19 vaccine in May. Initially, the CDMO will manufacture the vaccine active ingredient—an mRNA molecule in lipid nanoparticles—at plants in the United States and Switzerland. However, the firms plan to establish additional production suites […]


Industry, News, Pharma

Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for BPX-01 and BPX-04

September 15, 2020

Via: BioSpace

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that it has received a formal notice of allowance from the U.S. Patent […]


Clinical Trials, Manufacturing, Research and Development

CNS Pharmaceuticals Announces US Drug Manufacturing Milestones

September 3, 2020

Via: BioSpace

CNS PHARMACEUTICALS AG, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, today provides an update on progress for the U.S. manufacturing […]


Industry, Pharma

Drug Targets Identified More Discerningly

September 1, 2020

Via: Genetic Engineering and Biotechnology News

Experimental drugs face steep odds. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), out of every 5,000 to 10,000 compounds that enter the discovery and development pipeline, just 5 enter clinical trials, and only 1 receives approval. Other […]


FDA, Industry, Regulations, Vaccines

FDA Clears SPI’s Ebselen for Phase II COVID-19 Trials

August 31, 2020

Via: Contract Pharma

Sound Pharmaceuticals, Inc. (SPI) received clearance from the FDA to begin two Phase 2 studies of ebselen (SPI-1005) in COVID-19 patients. SPI-1005 is a novel anti-inflammatory drug which was recently shown to inhibit nCoV2 activity and viral replication. The two […]


Industry, Vaccines

AstraZeneca nets $396M down payment from EU for 300M-plus COVID vaccines

August 28, 2020

Via: FiercePharma

AstraZeneca has been on roll lately, inking COVID-19 vaccine supply deals left and right with countries worldwide. One of its highest-profile pacts—a purchase deal with the European Union—was made official earlier this month, and now, the trading bloc has floated […]


Cell and Gene Therapy, Industry

How a biotech CEO figured out Covid-19 surveillance testing for 50 companies with 12-hour turnaround times

August 14, 2020

Via: CNBC

When the Covid-19 pandemic struck the U.S., young biotech company Verve Therapeutics was just months away from a pivotal development: studies in animals of its gene-editing approach to lowering cholesterol that would lead it to be heralded as a potential […]


Industry, Vaccines

WHO warns against coronavirus ‘vaccine nationalism and risk of price gouging’

August 13, 2020

Via: CNBC

High demand for a safe and effective vaccine against the coronavirus is already causing competition between countries and could drive prices higher, the World Health Organization’s top official warned Thursday. “When a successful new vaccine is found, there will be […]


Industry, Pharma

Phio Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update

August 12, 2020

Via: BioSpace

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today reported its financial results for the quarter ended June 30, 2020 and provided a business […]


Industry, Vaccines

Merck to Move COVID-19 Vaccine Candidate into Phase I in Q3

July 31, 2020

Via: BioSpace

Merck is joining the ranks of pharmaceutical companies that have a COVID-19 vaccine candidate in clinical development. Merck will move its candidate into clinical trials in the third quarter of this year, the company announced this morning. The move to […]